high non-GTN neoplastic hCG

Type of Tumor	Authors	Age (yr), Gender	Serum ß-hCG (mIU/ml)
Lung carcinoma	Sagaster et al, 2001	30, female	449
	Yoshida et al, 2000	31, female	12 238
	Arano et al, 1994	72, female	N / A
	Matsushima et al, 1980	74, female	2 540
	Hatch et al, 1980	24, female	16
	Manzi et al, 1995	31, female	146
	Snyder et al, 1995	42, female	180
	Snyder et al, 1995	49, female	929
	Nimi et al, 1992	73 male	1 108
Osteosarcoma	Leidinger et al, 2004	18, female	717
Cervix carcinoma	Coleman et al, 2000	32, female	40
Pancreatic carcinoma	Yoong et al, 2005	46, female	150
Leiomyosarcoma	Meredith et al, 1986	22, female	7 550
Squamous cell carcinoma of maxilla	Scholl et al, 1997	47 male	92.4
colorectal cancers	Mashiach et al, 1995	47, female	50
Hepatocellular cancer	Dahan and Kastell, 2002	44, female	N / A
Eccrine adenoca of vulva	Fukuma et al, 1986	69	800
meningioma	Rau et al, 2002	36, female	15 992

“…Elevated serum and urinary β-hCG levels in healthy women should be systematically investigated to exclude an underlying malignant process and to avoid inappropriate surgical and medical intervention. Long-term follow-up is required as tumors may not become apparent for many months or years…”

2007. Demirtas et al. Ob Gyn Survey 62 (2007) 675-679 ;

2007. Palmieri et al. Gynecol Oncol 106 (2007) 35–43 .

Modified on 12/23/2023